In drug development, PET scans play a critical role in preclinical studies, allowing researchers to assess drug delivery, uptake, and action in target tissues. This information is invaluable for optimizing drug formulations and dosages. PET imaging can help determine the therapeutic window of a drug, reducing the risk of adverse effects and improving patient safety.
